UNITY Biotechnology Inc UBX:NASDAQ

Earnings Announcement Next Earnings date is expected on 08/16/2022
Last Price$1.31NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change0(0.00%)
Bid (Size)$1.35 (154)
Ask (Size)$1.36 (34)
Day Low / HighN/A - N/A
Volume94.5 M
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

UNITY Biotechnology Inc ( NASDAQ )

Price: $1.31
Change: +0.46 (54.10%)
Volume: 94.5 M
4:00PM ET 8/12/2022
 
 

Solid Biosciences Inc ( NASDAQ )

Price: $0.80
Change: +0.02 (2.73%)
Volume: 604.4 K
4:00PM ET 8/12/2022
 
 

Equillium Inc ( NASDAQ )

Price: $2.82
Change: +0.08 (2.92%)
Volume: 18.7 K
3:59PM ET 8/12/2022
 
 

X4 Pharmaceuticals Inc ( NASDAQ )

Price: $1.42
Change: -0.01 (0.70%)
Volume: 398.3 K
4:00PM ET 8/12/2022
 
 

Quince Therapeutics Inc ( NASDAQ )

Price: $2.34
Change: -0.03 (1.27%)
Volume: 226.9 K
4:00PM ET 8/12/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Extending Friday Recovery
4:06PM ET 8/12/2022 MT Newswires

Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index, the SPDR Health Care Select Sector ETF (XLV) and the Nasdaq...

Sector Update: Health Care Stocks Adding to Morning Advance
1:50PM ET 8/12/2022 MT Newswires

Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both gaining 1.0%. ...

Sector Update: Health Care
1:32PM ET 8/12/2022 MT Newswires

Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) each gaining 1.0%....

Wall Street Set for Gains Ahead of Consumer Sentiment Index
9:16AM ET 8/12/2022 MT Newswires

US stocks were set for a higher open Friday as traders looked ahead to a reading on consumer sentiment. Dow Jones Industrial Average futures gained 0.4%,...

View all Commentary and Analysis

Unity Biotechnology (UBX) Investor Presentation - Slideshow
4:59PM ET 3/04/2022 Seeking Alpha

Company Profile

Business DescriptionUnity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA. View company web site for more details
Address285 East Grand Avenue
South San Francisco, California 94080
Phone+1.650.416.1192
Number of Employees106
Recent SEC Filing08/12/202210-Q
Chief Executive Officer & DirectorAnirvan Ghosh
Vice President-OperationsNathan Guz
Chief Financial OfficerLynne Sullivan
Chief Medical OfficerJamie Dananberg

Company Highlights

Price Open$1.83
Previous Close$0.85
52 Week Range$0.55 - 3.68
Market Capitalization$90.6 M
Shares Outstanding69.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/16/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.08
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-1,335.37%
Return on Equity-109.24%

Analyst Ratings as of 05/12/2022

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset